المؤلفون: Aksoylar HI; Division of Hematology-Oncology Beth Israel Deaconess Medical Center Harvard Medical School, Boston, MA, 02215, USA.; Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Patsoukis N; Division of Hematology-Oncology Beth Israel Deaconess Medical Center Harvard Medical School, Boston, MA, 02215, USA.; Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

المصدر: Advanced biology [Adv Biol (Weinh)] 2023 Apr; Vol. 7 (4), pp. e2101320. Date of Electronic Publication: 2022 Apr 28.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-VCH GmbH Country of Publication: Germany NLM ID: 101775319 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2701-0198 (Electronic) Linking ISSN: 27010198 NLM ISO Abbreviation: Adv Biol (Weinh) Subsets: MEDLINE

مواضيع طبية MeSH: CD8-Positive T-Lymphocytes*/metabolism , Antioxidants*/metabolism, Catalase/metabolism ; Reactive Oxygen Species ; Cell Differentiation

المؤلفون: Christofides A; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Medicine, Yale University, New Haven, CT, USA., Katopodi XL; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Harvard Medical School Initiative for RNA Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Cao C; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Harvard College, Cambridge, MA, USA., Karagkouni D; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Harvard Medical School Initiative for RNA Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Aliazis K; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA., Yenyuwadee S; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Aksoylar HI; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA., Pal R; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA., Mahmoud MAA; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Heidelberg University, German Cancer Research Center (DKFZ), Heidelberg, Germany., Strauss L; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Sanofi /Tidal, Cambridge, MA, USA., Tijaro-Ovalle NM; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Department of Medicine, Yale University, New Haven, CT, USA., Boon L; JJP Biologics, Warsaw, Poland., Asara J; Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA., Vlachos IS; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Harvard Medical School Initiative for RNA Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Cancer Research Institute, Beth Israel Deaconess Medical Center, Boston, MA, USA., Patsoukis N; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA., Boussiotis VA; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA. vboussio@bidmc.harvard.edu.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. vboussio@bidmc.harvard.edu.; Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA. vboussio@bidmc.harvard.edu.

المصدر: Nature immunology [Nat Immunol] 2023 Jan; Vol. 24 (1), pp. 55-68. Date of Electronic Publication: 2022 Dec 29.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Granulocyte-Macrophage Colony-Stimulating Factor*/genetics , Neoplasms*, Animals ; Mice ; Cell Differentiation ; Myeloid Cells ; Programmed Cell Death 1 Receptor/genetics ; Protein Tyrosine Phosphatase, Non-Receptor Type 6 ; Signal Transduction

المؤلفون: Christofides A; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School., Cao C; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School; Harvard College., Pal R; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School., Aksoylar HI; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School., Boussiotis VA; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School; vboussio@bidmc.harvard.edu.

المصدر: Journal of visualized experiments : JoVE [J Vis Exp] 2021 Nov 16 (177). Date of Electronic Publication: 2021 Nov 16.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Video-Audio Media

بيانات الدورية: Publisher: MYJoVE Corporation Country of Publication: United States NLM ID: 101313252 Publication Model: Electronic Cited Medium: Internet ISSN: 1940-087X (Electronic) Linking ISSN: 1940087X NLM ISO Abbreviation: J Vis Exp Subsets: MEDLINE

مواضيع طبية MeSH: Immunity, Innate* , Lung*, Animals ; Flow Cytometry/methods ; Immunophenotyping ; Mice

المؤلفون: Aksoylar HI; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Boussiotis VA; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. vboussio@bidmc.harvard.edu.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. vboussio@bidmc.harvard.edu.

المصدر: Nature immunology [Nat Immunol] 2020 Nov; Vol. 21 (11), pp. 1311-1312.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Comment

بيانات الدورية: Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/therapy , T-Lymphocytes, Regulatory*, Humans ; Immunotherapy ; Programmed Cell Death 1 Receptor ; Treatment Outcome

المؤلفون: Bardhan K; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Aksoylar HI; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Le Bourgeois T; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.; Antoine Lacassagne Cancer Institute of Nice, Medical University of Nice Sophia Antipolis, Sophia Antipolis, France., Strauss L; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Weaver JD; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.; Jounce Therapeutics, 780 Memorial Drive, Cambridge, MA, USA., Delcuze B; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Charest A; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.; Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Patsoukis N; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Boussiotis VA; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA. vboussio@bidmc.harvard.edu.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA. vboussio@bidmc.harvard.edu.; Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA. vboussio@bidmc.harvard.edu.

المصدر: Scientific reports [Sci Rep] 2020 Sep 23; Vol. 10 (1), pp. 15905. Date of Electronic Publication: 2020 Sep 23.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Patsoukis N; Division of Hematology-Oncology Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA.; Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Duke-Cohan JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Chaudhri A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, 77030, USA., Aksoylar HI; Division of Hematology-Oncology Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA.; Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Wang Q; Division of Hematology-Oncology Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA.; Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Council A; Division of Hematology-Oncology Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA.; Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Berg A; Department of Pathology Beth Israel Deaconess Cancer Center, Harvard Medical School, Boston, MA, 02215, USA.; Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Freeman GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Boussiotis VA; Division of Hematology-Oncology Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA. vboussio@bidmc.harvard.edu.; Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA. vboussio@bidmc.harvard.edu.

المصدر: Communications biology [Commun Biol] 2020 Mar 17; Vol. 3 (1), pp. 128. Date of Electronic Publication: 2020 Mar 17.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE

مواضيع طبية MeSH: Programmed Cell Death 1 Receptor/*metabolism , Protein Tyrosine Phosphatase, Non-Receptor Type 11/*metabolism , T-Lymphocytes/*enzymology, Animals ; COS Cells ; Chlorocebus aethiops ; Enzyme Activation ; HEK293 Cells ; Humans ; Immunoreceptor Tyrosine-Based Activation Motif ; Jurkat Cells ; Mice, Knockout ; Phosphorylation ; Programmed Cell Death 1 Receptor/chemistry ; Programmed Cell Death 1 Receptor/genetics ; Protein Binding ; Protein Multimerization ; Protein Tyrosine Phosphatase, Non-Receptor Type 11/chemistry ; Protein Tyrosine Phosphatase, Non-Receptor Type 11/genetics ; Proto-Oncogene Proteins c-fyn/genetics ; Proto-Oncogene Proteins c-fyn/metabolism ; src Homology Domains

المؤلفون: Aksoylar HI; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Tijaro-Ovalle NM; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Boussiotis VA; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Patsoukis N; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

المصدر: Immunometabolism [Immunometabolism] 2020; Vol. 2 (3). Date of Electronic Publication: 2020 Jun 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Walter de Gruyter GmbH Country of Publication: Germany NLM ID: 101607751 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2084-6835 (Print) NLM ISO Abbreviation: Immunometabolism Subsets: PubMed not MEDLINE

المؤلفون: Bardhan K; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, United States.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, United States., Aksoylar HI; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, United States.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, United States., Le Bourgeois T; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, United States.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, United States.; Antoine Lacassagne Cancer Institute of Nice, Medical University of Nice Sophia Antipolis, Sophia Antipolis, France., Strauss L; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, United States.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, United States., Weaver JD; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, United States.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, United States.; Jounce Therapeutics, 780 Memorial Drive, Cambridge, Massachusetts, United States., Delcuze B; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, United States., Charest A; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, United States.; Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, United States., Patsoukis N; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, United States.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, United States., Boussiotis VA; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, United States. vboussio@bidmc.harvard.edu.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, United States. vboussio@bidmc.harvard.edu.; Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, United States. vboussio@bidmc.harvard.edu.

المصدر: Scientific reports [Sci Rep] 2019 Nov 21; Vol. 9 (1), pp. 17252. Date of Electronic Publication: 2019 Nov 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: CD8-Positive T-Lymphocytes/*metabolism , Immunoreceptor Tyrosine-Based Inhibition Motif/*physiology , Programmed Cell Death 1 Receptor/*metabolism, Animals ; Antigens, CD/metabolism ; Apoptosis/immunology ; Apoptosis Regulatory Proteins/metabolism ; Biomarkers/blood ; CD28 Antigens/metabolism ; Female ; Glioblastoma/genetics ; Glioblastoma/metabolism ; Humans ; Immunoreceptor Tyrosine-Based Inhibition Motif/genetics ; Killer Cells, Natural/immunology ; Male ; Mice ; Mice, Inbred C57BL ; Phosphorylation ; Primary Cell Culture ; Programmed Cell Death 1 Receptor/genetics ; Receptors, Immunologic/metabolism ; Signal Transduction/immunology ; T-Lymphocytes/metabolism ; Tyrosine/metabolism

المؤلفون: Langston PK; Department of Genetics & Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Nambu A; Department of Genetics & Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Jung J; Department of Genetics & Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; School of Medicine, University of Glasgow, Glasgow, UK., Shibata M; Department of Genetics & Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Aksoylar HI; Department of Genetics & Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Lei J; Department of Genetics & Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Xu P; A.J. Drexel Autism Institute, Drexel University, Philadelphia, PA, USA., Doan MT; A.J. Drexel Autism Institute, Drexel University, Philadelphia, PA, USA., Jiang H; A.J. Drexel Autism Institute, Drexel University, Philadelphia, PA, USA., MacArthur MR; Department of Genetics & Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Gao X; Department of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, NC, USA., Kong Y; Depart of Immunobiology, Yale University School of Medicine, New Haven, CT, USA., Chouchani ET; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Locasale JW; Department of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, NC, USA., Snyder NW; A.J. Drexel Autism Institute, Drexel University, Philadelphia, PA, USA., Horng T; Department of Genetics & Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA. tsyhorng@shanghaitech.edu.cn.; School of Life Sciences and Technology, ShanghaiTech University, Shanghai, China. tsyhorng@shanghaitech.edu.cn.

المصدر: Nature immunology [Nat Immunol] 2019 Nov; Vol. 20 (11), pp. 1555.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Langston PK; Department of Genetics & Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Nambu A; Department of Genetics & Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Jung J; Department of Genetics & Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; School of Medicine, University of Glasgow, Glasgow, UK., Shibata M; Department of Genetics & Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Aksoylar HI; Department of Genetics & Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Lei J; Department of Genetics & Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Xu P; A.J. Drexel Autism Institute, Drexel University, Philadelphia, PA, USA., Doan MT; A.J. Drexel Autism Institute, Drexel University, Philadelphia, PA, USA., Jiang H; A.J. Drexel Autism Institute, Drexel University, Philadelphia, PA, USA., MacArthur MR; Department of Genetics & Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Gao X; Department of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, NC, USA., Kong Y; Depart of Immunobiology, Yale University School of Medicine, New Haven, CT, USA., Chouchani ET; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Locasale JW; Department of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, NC, USA., Snyder NW; A.J. Drexel Autism Institute, Drexel University, Philadelphia, PA, USA., Horng T; Department of Genetics & Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA. tsyhorng@shanghaitech.edu.cn.; School of Life Sciences and Technology, ShanghaiTech University, Shanghai, China. tsyhorng@shanghaitech.edu.cn.

المصدر: Nature immunology [Nat Immunol] 2019 Sep; Vol. 20 (9), pp. 1186-1195. Date of Electronic Publication: 2019 Aug 05.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Glucose/*metabolism , Glycerolphosphate Dehydrogenase/*metabolism , Macrophage Activation/*immunology , Macrophages/*immunology , Macrophages/*metabolism, Acetyl Coenzyme A/biosynthesis ; Acetylation ; Animals ; Female ; Histones/metabolism ; Inflammation/pathology ; Lipopolysaccharides ; Macrophages/cytology ; Male ; Mice ; Mice, Inbred C57BL ; Oxidation-Reduction